Global Metoprolol Succinate Market

Metoprolol Succinate Comprehensive Study by Type (25mg, 50mg, 100mg, 200mg), Application (Hypertension, Angina, Others), Shape (Round, Oblong, Oval), Distribution Channel (Hospitals, Drug Stores, Hospital Pharmacies, Online Drug Stores), End User (Research Centers, Hospital, Clinic) Players and Region - Global Market Outlook to 2025

Metoprolol Succinate Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Metoprolol Succinate Market Scope
Metoprolol Succinate is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.

The Metoprolol Succinate market study is segmented by Type (25mg, 50mg, 100mg and 200mg), by Application (Hypertension, Angina and Others) and major geographies with country level break-up.

The market is fragmented by key vendors who are focusing on production technologies, improving efficiency, and shelf life. Growth opportunities can be captured by tracking the ongoing process improvement and financial flexibility to invest in optimal strategies. Research Analyst at AMA estimates that United States and India Players will contribute to the maximum growth of Global Metoprolol Succinate market throughout the predicted period.

Lannett Co Inc (United States), Hema Pharmaceuticals (India), Ravoos Laboratories Limited (India), Aralez (Canada), AstraZeneca plc (United Kingdom), Tecoland (United States), Surya Life Sciences Ltd (India), Cipla Limited (India) and Sun Pharmaceutical Industries Limited (India) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Metoprolol Succinate market by Type, Application and Region.

On the basis of geography, the market of Metoprolol Succinate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In Oct 2018, Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application(ANDA) for Metoprolol ER Tablets 50mg, 100mg, 200mg from the United StatesFood and Drug Administration (US FDA)., and In Aug 2018, Sun Pharmaceutical Industries Ltd. announced that Sun Pharma has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules in the US, for the treatment of hypertension (to lower blood pressure), angina pectoris (chest pain), and heart failure (to reduce the risk of cardiovascular mortality and heart failure hospitalization in patients with heart failure).


Market Trend
  • Technological advancements in Production of Pharmaceuticals

Market Drivers
  • Increasing Number of Hypertensive Patients across the world
  • Growing Cardiovascular Diseases such as High Blood Pressure Amongst Old Age Population

Opportunities
  • Growing Demand from Emerging Market such as China, India, Brazil, among others
  • The Growth in Number of Geriatric Population Across the Globe

Restraints
  • Issue related to Some Side Effect of Drugs

Challenges
  • Stringent Regulatory Policies by Governing Bodies Coupled With High Cost of Clinical Trials


Key Target Audience
Manufacturers of Metoprolol Succinate, Suppliers of Metoprolol Succinate, Raw MAterial Suppliers, Research and Development (R&D) Companies, Research Organization, Federal Agencies, Potential Investors and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • 25mg
  • 50mg
  • 100mg
  • 200mg
By Application
  • Hypertension
  • Angina
  • Others
By Shape
  • Round
  • Oblong
  • Oval

By Distribution Channel
  • Hospitals
  • Drug Stores
  • Hospital Pharmacies
  • Online Drug Stores

By End User
  • Research Centers
  • Hospital
  • Clinic

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Hypertensive Patients across the world
      • 3.2.2. Growing Cardiovascular Diseases such as High Blood Pressure Amongst Old Age Population
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Policies by Governing Bodies Coupled With High Cost of Clinical Trials
    • 3.4. Market Trends
      • 3.4.1. Technological advancements in Production of Pharmaceuticals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Metoprolol Succinate, by Type, Application, Shape, Distribution Channel, End User and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Metoprolol Succinate (Value)
      • 5.2.1. Global Metoprolol Succinate by: Type (Value)
        • 5.2.1.1. 25mg
        • 5.2.1.2. 50mg
        • 5.2.1.3. 100mg
        • 5.2.1.4. 200mg
      • 5.2.2. Global Metoprolol Succinate by: Application (Value)
        • 5.2.2.1. Hypertension
        • 5.2.2.2. Angina
        • 5.2.2.3. Others
      • 5.2.3. Global Metoprolol Succinate by: Shape (Value)
        • 5.2.3.1. Round
        • 5.2.3.2. Oblong
        • 5.2.3.3. Oval
      • 5.2.4. Global Metoprolol Succinate by: Distribution Channel (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Drug Stores
        • 5.2.4.3. Hospital Pharmacies
        • 5.2.4.4. Online Drug Stores
      • 5.2.5. Global Metoprolol Succinate by: End User (Value)
        • 5.2.5.1. Research Centers
        • 5.2.5.2. Hospital
        • 5.2.5.3. Clinic
      • 5.2.6. Global Metoprolol Succinate Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Metoprolol Succinate: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Lannett Co Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hema Pharmaceuticals (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ravoos Laboratories Limited (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aralez (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca plc (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Tecoland (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Surya Life Sciences Ltd (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cipla Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sun Pharmaceutical Industries Limited (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Metoprolol Succinate Sale, by Type, Application, Shape, Distribution Channel, End User and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Metoprolol Succinate (Value)
      • 7.2.1. Global Metoprolol Succinate by: Type (Value)
        • 7.2.1.1. 25mg
        • 7.2.1.2. 50mg
        • 7.2.1.3. 100mg
        • 7.2.1.4. 200mg
      • 7.2.2. Global Metoprolol Succinate by: Application (Value)
        • 7.2.2.1. Hypertension
        • 7.2.2.2. Angina
        • 7.2.2.3. Others
      • 7.2.3. Global Metoprolol Succinate by: Shape (Value)
        • 7.2.3.1. Round
        • 7.2.3.2. Oblong
        • 7.2.3.3. Oval
      • 7.2.4. Global Metoprolol Succinate by: Distribution Channel (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Drug Stores
        • 7.2.4.3. Hospital Pharmacies
        • 7.2.4.4. Online Drug Stores
      • 7.2.5. Global Metoprolol Succinate by: End User (Value)
        • 7.2.5.1. Research Centers
        • 7.2.5.2. Hospital
        • 7.2.5.3. Clinic
      • 7.2.6. Global Metoprolol Succinate Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Metoprolol Succinate: by Type(USD Million)
  • Table 2. Metoprolol Succinate 25mg , by Region USD Million (2014-2019)
  • Table 3. Metoprolol Succinate 50mg , by Region USD Million (2014-2019)
  • Table 4. Metoprolol Succinate 100mg , by Region USD Million (2014-2019)
  • Table 5. Metoprolol Succinate 200mg , by Region USD Million (2014-2019)
  • Table 6. Metoprolol Succinate: by Application(USD Million)
  • Table 7. Metoprolol Succinate Hypertension , by Region USD Million (2014-2019)
  • Table 8. Metoprolol Succinate Angina , by Region USD Million (2014-2019)
  • Table 9. Metoprolol Succinate Others , by Region USD Million (2014-2019)
  • Table 10. Metoprolol Succinate: by Shape(USD Million)
  • Table 11. Metoprolol Succinate Round , by Region USD Million (2014-2019)
  • Table 12. Metoprolol Succinate Oblong , by Region USD Million (2014-2019)
  • Table 13. Metoprolol Succinate Oval , by Region USD Million (2014-2019)
  • Table 14. Metoprolol Succinate: by Distribution Channel(USD Million)
  • Table 15. Metoprolol Succinate Hospitals , by Region USD Million (2014-2019)
  • Table 16. Metoprolol Succinate Drug Stores , by Region USD Million (2014-2019)
  • Table 17. Metoprolol Succinate Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 18. Metoprolol Succinate Online Drug Stores , by Region USD Million (2014-2019)
  • Table 19. Metoprolol Succinate: by End User(USD Million)
  • Table 20. Metoprolol Succinate Research Centers , by Region USD Million (2014-2019)
  • Table 21. Metoprolol Succinate Hospital , by Region USD Million (2014-2019)
  • Table 22. Metoprolol Succinate Clinic , by Region USD Million (2014-2019)
  • Table 23. South America Metoprolol Succinate, by Country USD Million (2014-2019)
  • Table 24. South America Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 25. South America Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 26. South America Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 27. South America Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 28. South America Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 29. Brazil Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 30. Brazil Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 31. Brazil Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 32. Brazil Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 33. Brazil Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 34. Argentina Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 35. Argentina Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 36. Argentina Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 37. Argentina Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 38. Argentina Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 39. Rest of South America Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 40. Rest of South America Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 41. Rest of South America Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 42. Rest of South America Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 43. Rest of South America Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 44. Asia Pacific Metoprolol Succinate, by Country USD Million (2014-2019)
  • Table 45. Asia Pacific Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 46. Asia Pacific Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 47. Asia Pacific Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 48. Asia Pacific Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 49. Asia Pacific Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 50. China Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 51. China Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 52. China Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 53. China Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 54. China Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 55. Japan Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 56. Japan Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 57. Japan Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 58. Japan Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 59. Japan Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 60. India Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 61. India Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 62. India Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 63. India Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 64. India Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 65. South Korea Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 66. South Korea Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 67. South Korea Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 68. South Korea Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 69. South Korea Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 70. Taiwan Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 71. Taiwan Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 72. Taiwan Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 73. Taiwan Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 74. Taiwan Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 75. Australia Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 76. Australia Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 77. Australia Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 78. Australia Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 79. Australia Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 80. Rest of Asia-Pacific Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 81. Rest of Asia-Pacific Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 82. Rest of Asia-Pacific Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 83. Rest of Asia-Pacific Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 84. Rest of Asia-Pacific Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 85. Europe Metoprolol Succinate, by Country USD Million (2014-2019)
  • Table 86. Europe Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 87. Europe Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 88. Europe Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 89. Europe Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 90. Europe Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 91. Germany Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 92. Germany Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 93. Germany Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 94. Germany Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 95. Germany Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 96. France Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 97. France Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 98. France Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 99. France Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 100. France Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 101. Italy Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 102. Italy Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 103. Italy Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 104. Italy Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 105. Italy Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 106. United Kingdom Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 107. United Kingdom Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 108. United Kingdom Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 109. United Kingdom Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 110. United Kingdom Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 111. Netherlands Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 112. Netherlands Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 113. Netherlands Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 114. Netherlands Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 115. Netherlands Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 116. Rest of Europe Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 117. Rest of Europe Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 118. Rest of Europe Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 119. Rest of Europe Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 120. Rest of Europe Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 121. MEA Metoprolol Succinate, by Country USD Million (2014-2019)
  • Table 122. MEA Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 123. MEA Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 124. MEA Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 125. MEA Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 126. MEA Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 127. Middle East Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 128. Middle East Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 129. Middle East Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 130. Middle East Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 131. Middle East Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 132. Africa Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 133. Africa Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 134. Africa Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 135. Africa Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 136. Africa Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 137. North America Metoprolol Succinate, by Country USD Million (2014-2019)
  • Table 138. North America Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 139. North America Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 140. North America Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 141. North America Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 142. North America Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 143. United States Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 144. United States Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 145. United States Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 146. United States Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 147. United States Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 148. Canada Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 149. Canada Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 150. Canada Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 151. Canada Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 152. Canada Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 153. Mexico Metoprolol Succinate, by Type USD Million (2014-2019)
  • Table 154. Mexico Metoprolol Succinate, by Application USD Million (2014-2019)
  • Table 155. Mexico Metoprolol Succinate, by Shape USD Million (2014-2019)
  • Table 156. Mexico Metoprolol Succinate, by Distribution Channel USD Million (2014-2019)
  • Table 157. Mexico Metoprolol Succinate, by End User USD Million (2014-2019)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Metoprolol Succinate: by Type(USD Million)
  • Table 168. Metoprolol Succinate 25mg , by Region USD Million (2020-2025)
  • Table 169. Metoprolol Succinate 50mg , by Region USD Million (2020-2025)
  • Table 170. Metoprolol Succinate 100mg , by Region USD Million (2020-2025)
  • Table 171. Metoprolol Succinate 200mg , by Region USD Million (2020-2025)
  • Table 172. Metoprolol Succinate: by Application(USD Million)
  • Table 173. Metoprolol Succinate Hypertension , by Region USD Million (2020-2025)
  • Table 174. Metoprolol Succinate Angina , by Region USD Million (2020-2025)
  • Table 175. Metoprolol Succinate Others , by Region USD Million (2020-2025)
  • Table 176. Metoprolol Succinate: by Shape(USD Million)
  • Table 177. Metoprolol Succinate Round , by Region USD Million (2020-2025)
  • Table 178. Metoprolol Succinate Oblong , by Region USD Million (2020-2025)
  • Table 179. Metoprolol Succinate Oval , by Region USD Million (2020-2025)
  • Table 180. Metoprolol Succinate: by Distribution Channel(USD Million)
  • Table 181. Metoprolol Succinate Hospitals , by Region USD Million (2020-2025)
  • Table 182. Metoprolol Succinate Drug Stores , by Region USD Million (2020-2025)
  • Table 183. Metoprolol Succinate Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 184. Metoprolol Succinate Online Drug Stores , by Region USD Million (2020-2025)
  • Table 185. Metoprolol Succinate: by End User(USD Million)
  • Table 186. Metoprolol Succinate Research Centers , by Region USD Million (2020-2025)
  • Table 187. Metoprolol Succinate Hospital , by Region USD Million (2020-2025)
  • Table 188. Metoprolol Succinate Clinic , by Region USD Million (2020-2025)
  • Table 189. South America Metoprolol Succinate, by Country USD Million (2020-2025)
  • Table 190. South America Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 191. South America Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 192. South America Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 193. South America Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 194. South America Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 195. Brazil Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 196. Brazil Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 197. Brazil Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 198. Brazil Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 199. Brazil Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 200. Argentina Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 201. Argentina Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 202. Argentina Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 203. Argentina Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 204. Argentina Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 205. Rest of South America Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 206. Rest of South America Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 207. Rest of South America Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 208. Rest of South America Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 209. Rest of South America Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 210. Asia Pacific Metoprolol Succinate, by Country USD Million (2020-2025)
  • Table 211. Asia Pacific Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 212. Asia Pacific Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 213. Asia Pacific Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 214. Asia Pacific Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 215. Asia Pacific Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 216. China Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 217. China Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 218. China Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 219. China Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 220. China Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 221. Japan Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 222. Japan Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 223. Japan Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 224. Japan Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 225. Japan Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 226. India Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 227. India Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 228. India Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 229. India Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 230. India Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 231. South Korea Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 232. South Korea Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 233. South Korea Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 234. South Korea Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 235. South Korea Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 236. Taiwan Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 237. Taiwan Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 238. Taiwan Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 239. Taiwan Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 240. Taiwan Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 241. Australia Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 242. Australia Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 243. Australia Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 244. Australia Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 245. Australia Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 246. Rest of Asia-Pacific Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 247. Rest of Asia-Pacific Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 248. Rest of Asia-Pacific Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 249. Rest of Asia-Pacific Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 250. Rest of Asia-Pacific Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 251. Europe Metoprolol Succinate, by Country USD Million (2020-2025)
  • Table 252. Europe Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 253. Europe Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 254. Europe Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 255. Europe Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 256. Europe Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 257. Germany Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 258. Germany Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 259. Germany Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 260. Germany Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 261. Germany Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 262. France Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 263. France Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 264. France Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 265. France Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 266. France Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 267. Italy Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 268. Italy Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 269. Italy Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 270. Italy Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 271. Italy Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 272. United Kingdom Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 273. United Kingdom Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 274. United Kingdom Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 275. United Kingdom Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 276. United Kingdom Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 277. Netherlands Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 278. Netherlands Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 279. Netherlands Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 280. Netherlands Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 281. Netherlands Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 282. Rest of Europe Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 283. Rest of Europe Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 284. Rest of Europe Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 285. Rest of Europe Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 286. Rest of Europe Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 287. MEA Metoprolol Succinate, by Country USD Million (2020-2025)
  • Table 288. MEA Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 289. MEA Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 290. MEA Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 291. MEA Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 292. MEA Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 293. Middle East Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 294. Middle East Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 295. Middle East Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 296. Middle East Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 297. Middle East Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 298. Africa Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 299. Africa Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 300. Africa Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 301. Africa Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 302. Africa Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 303. North America Metoprolol Succinate, by Country USD Million (2020-2025)
  • Table 304. North America Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 305. North America Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 306. North America Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 307. North America Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 308. North America Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 309. United States Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 310. United States Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 311. United States Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 312. United States Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 313. United States Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 314. Canada Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 315. Canada Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 316. Canada Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 317. Canada Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 318. Canada Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 319. Mexico Metoprolol Succinate, by Type USD Million (2020-2025)
  • Table 320. Mexico Metoprolol Succinate, by Application USD Million (2020-2025)
  • Table 321. Mexico Metoprolol Succinate, by Shape USD Million (2020-2025)
  • Table 322. Mexico Metoprolol Succinate, by Distribution Channel USD Million (2020-2025)
  • Table 323. Mexico Metoprolol Succinate, by End User USD Million (2020-2025)
  • Table 324. Research Programs/Design for This Report
  • Table 325. Key Data Information from Secondary Sources
  • Table 326. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Metoprolol Succinate: by Type USD Million (2014-2019)
  • Figure 5. Global Metoprolol Succinate: by Application USD Million (2014-2019)
  • Figure 6. Global Metoprolol Succinate: by Shape USD Million (2014-2019)
  • Figure 7. Global Metoprolol Succinate: by Distribution Channel USD Million (2014-2019)
  • Figure 8. Global Metoprolol Succinate: by End User USD Million (2014-2019)
  • Figure 9. South America Metoprolol Succinate Share (%), by Country
  • Figure 10. Asia Pacific Metoprolol Succinate Share (%), by Country
  • Figure 11. Europe Metoprolol Succinate Share (%), by Country
  • Figure 12. MEA Metoprolol Succinate Share (%), by Country
  • Figure 13. North America Metoprolol Succinate Share (%), by Country
  • Figure 14. Global Metoprolol Succinate share by Players 2019 (%)
  • Figure 15. Global Metoprolol Succinate share by Players (Top 3) 2019(%)
  • Figure 16. Global Metoprolol Succinate share by Players (Top 5) 2019(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Lannett Co Inc (United States) Revenue, Net Income and Gross profit
  • Figure 19. Lannett Co Inc (United States) Revenue: by Geography 2019
  • Figure 20. Hema Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 21. Hema Pharmaceuticals (India) Revenue: by Geography 2019
  • Figure 22. Ravoos Laboratories Limited (India) Revenue, Net Income and Gross profit
  • Figure 23. Ravoos Laboratories Limited (India) Revenue: by Geography 2019
  • Figure 24. Aralez (Canada) Revenue, Net Income and Gross profit
  • Figure 25. Aralez (Canada) Revenue: by Geography 2019
  • Figure 26. AstraZeneca plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. AstraZeneca plc (United Kingdom) Revenue: by Geography 2019
  • Figure 28. Tecoland (United States) Revenue, Net Income and Gross profit
  • Figure 29. Tecoland (United States) Revenue: by Geography 2019
  • Figure 30. Surya Life Sciences Ltd (India) Revenue, Net Income and Gross profit
  • Figure 31. Surya Life Sciences Ltd (India) Revenue: by Geography 2019
  • Figure 32. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 33. Cipla Limited (India) Revenue: by Geography 2019
  • Figure 34. Sun Pharmaceutical Industries Limited (India) Revenue, Net Income and Gross profit
  • Figure 35. Sun Pharmaceutical Industries Limited (India) Revenue: by Geography 2019
  • Figure 36. Global Metoprolol Succinate: by Type USD Million (2020-2025)
  • Figure 37. Global Metoprolol Succinate: by Application USD Million (2020-2025)
  • Figure 38. Global Metoprolol Succinate: by Shape USD Million (2020-2025)
  • Figure 39. Global Metoprolol Succinate: by Distribution Channel USD Million (2020-2025)
  • Figure 40. Global Metoprolol Succinate: by End User USD Million (2020-2025)
  • Figure 41. South America Metoprolol Succinate Share (%), by Country
  • Figure 42. Asia Pacific Metoprolol Succinate Share (%), by Country
  • Figure 43. Europe Metoprolol Succinate Share (%), by Country
  • Figure 44. MEA Metoprolol Succinate Share (%), by Country
  • Figure 45. North America Metoprolol Succinate Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Lannett Co Inc (United States)
  • Hema Pharmaceuticals (India)
  • Ravoos Laboratories Limited (India)
  • Aralez (Canada)
  • AstraZeneca plc (United Kingdom)
  • Tecoland (United States)
  • Surya Life Sciences Ltd (India)
  • Cipla Limited (India)
  • Sun Pharmaceutical Industries Limited (India)
Select User Access Type

Key Highlights of Report


Oct 2020 203 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Metoprolol Succinate Market Quantitative research analysis
Global Metoprolol Succinate Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Metoprolol Succinate Market Report?

Have a Query? Click Here

Other Related Reports

Camel Milk Capsules Comprehensive Study by Type (Full Cream Camel Milk Capsules, Skimmed Camel Milk Capsules), Distribution Channel (Online Retail, Offline Retail) Players and Region - Global Market ...
$ 3500
Macrolide Antibiotics Comprehensive Study by Type (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), Application (Ear, Nose and Throat Infections, Chest Infections, Skin Infect...
$ 3750
Athlete's Foot Drugs Comprehensive Study by Type (OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate), Prescription Medications (itraconazole, fluconazole, prescription...
$ 3750
Medical Morphine Comprehensive Study by Type (Tablets, Capsule, Injectable), Application (Anesthesia, Cough Suppressant, Diarrhea Suppressant, Other), Distribution Chanel (Online, Offline) Players an...
$ 3500
Mometasone Furoate Ointment Comprehensive Study by Type (10g/Box, 15g/Box), Application (Eczema, Dermatitis, Allergies, Rash), Distribution Channel (Online, Medical Stores, Super Markets, Specialty S...
$ 3450
Detox Product Comprehensive Study by Type (Pharmaceuticals, Food Supplement, Cosmetics), Application (Supermarket, Convenience Stores, Specialty Stores, Online Stores, Other), Origin (Organic, Conven...
$ 3450